関連する実験動画

Updated: Sep 10, 2025

Resting-State Connectivity and Neuroimaging of Prefrontal Cortex Activity During a Block-Design Yoga Asana Practice Using fNIRS

Resting-State Connectivity and Neuroimaging of Prefrontal Cortex Activity During a Block-Design Yoga Asana Practice Using fNIRS

Published on: June 24, 2025

化学療法の脳に対するヨガ・ニドラの治療的可能性: 補完的で統合的な視点

Santosh Kumar Sahu¹, Ajit Kumar Pradhan¹

¹Department of AYUSH, All India Institute of Medical Sciences, Bhubaneswar, Odisha 751019, India.

Psychoradiology

|August 21, 2025

まとめ

化学療法による認知障害 (CICI) または"化学療法による脳"の管理にヨガニドラ (YN) は有望である. このガイデッド・リラクゼーション・テクニックは癌の生存者の記憶と注意を改善するのに役立ちます

科学分野:

統合腫瘍学
神経科学
精神生理学

背景:

化学療法による認知障害 (CICI) または"化学療法による脳"は癌の生存者にとって重要な課題であり記憶力や注意力や実行機能に影響します
CICIの現在の薬学的な治療法は有効性が限られており,補完的な介入の探求が必要である.
ヨガ・ニドラ (Yoga nidra,YN) は誘導によるヨガのリラクゼーション・プラクティスで神経認知や感情の調節のための非薬学的なアプローチとして発展している.

研究の目的:

化学療法による認知障害 (CICI) の管理におけるヨガ・ニドラ (YN) の新興する役割を調査する.
神経イメージングや認知神経科学や精神生理学の洞察を統合して化学療法による脳治療の潜在的メカニズムについて

主な方法:

PubMedとScopusがインデックスしたソースからのピアレビューされた文献の視点のレビュー.
神経イメージング,認知神経科学,精神生理学の研究の結果を統合したものです.
YNが脳波活動,自律機能,ストレスバイオマーカーに及ぼす影響の分析

主要な成果:

ヨガ・ニドラは神経認知と感情の調節に潜在的な利点を示しています
YNは,脳波活動,自律機能,およびCICI病理学に関連するストレスバイオマーカーに影響を与える可能性があります.
腫瘍学と神経リハビリテーションにおける補助療法としてのYNの可能性を示唆しています

結論:

ヨガ・ニドラは化学療法による脳症候群の治療に有望な補助手段です
CICIにおけるYNの治療メカニズムを完全に解明するには,機能的イメージングとバイオマーカー研究を含むさらなる研究が必要です.
YNは統合的腫瘍学と神経リハビリテーションの枠組みの中で潜在的な非侵襲的介入を提供します.

キーワード:

化学療法による脳機能神経イメージング心と身体の介入神経認知機能ストレスによる神経可塑性ヨガニドラ

さらに関連する動画

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting

Published on: June 21, 2024

Quantifying Cognitive Decrements Caused by Cranial Radiotherapy

Quantifying Cognitive Decrements Caused by Cranial Radiotherapy

Published on: October 18, 2011

関連する概念動画

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

Chemotherapy-Induced Nausea and Vomiting: 5-HT₃ Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Psychoneuroimmunology: Diabetes and Cancer

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...